Showing results (81-90 of 180) with videos related to

Sort By:
Pageof 18
American Journal of Hematology|December 6, 2025
Non-T-Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP/EBMTArnon Nagler, Sarah Kayser, Allain Thibeault Ferhat, et al.
Nature Communications|February 17, 2026
Adoptive γδ T cell therapy controls cytomegalovirus infection in preclinical transplantation modelsGabriel Marsères, Coline Gentil, Claire Tinevez, et al.
Bone Marrow Transplantation|December 19, 2020
Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC studyDavid Beauvais, Elodie Drumez, Didier Blaise, et al.
American Journal of Hematology|May 30, 2025
Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Allografted in First Remission: From EBMT ALWPAli Bazarbachi, Jacques-Emmanuel Galimard, Iman Abou Dalle, et al.
American Journal of Hematology|June 10, 2024
Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Bulletin Du Cancer|July 13, 2021
[Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Marie Thérèse Rubio, Pauline Varlet, Vincent Allain, et al.
Bone Marrow Transplantation|April 8, 2022
Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysisEduardo Rodríguez-Arbolí, Myriam Labopin, Matthias Eder, et al.
Bone Marrow Transplantation|May 5, 2023
Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years-a registry-based study by the Acute Leukemia Working Party of the EBMTKlaus Hirschbühl, Myriam Labopin, Emmanuelle Polge, et al.
Transplantation and Cellular Therapy|August 28, 2022
Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid LeukemiaArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Annals of the Rheumatic Diseases|July 21, 2021
TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosisPaôline Laurent, Benoit Allard, Pauline Manicki, et al.
Pageof 18